Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The complex challenges of HIV vaccine development require renewed and expanded global commitment.
Bekker LG, Tatoud R, Dabis F, Feinberg M, Kaleebu P, Marovich M, Ndung'u T, Russell N, Johnson J, Luba M, Fauci AS, Morris L, Pantaleo G, Buchbinder S, Gray G, Vekemans J, Kim JH, Levy Y, Corey L, Shattock R, Makanga M, Williamson C, Dieffenbach C, Goodenow MM, Shao Y, Staprans S, Warren M, Johnston MI. Bekker LG, et al. Among authors: levy y. Lancet. 2020 Feb 1;395(10221):384-388. doi: 10.1016/S0140-6736(19)32682-0. Epub 2019 Dec 2. Lancet. 2020. PMID: 31806257 Review. No abstract available.
Vaccine and immunotherapeutic interventions.
Pantaleo G, Lévy Y. Pantaleo G, et al. Among authors: levy y. Curr Opin HIV AIDS. 2013 May;8(3):236-42. doi: 10.1097/COH.0b013e32835fd5cd. Curr Opin HIV AIDS. 2013. PMID: 23478912 Review.
Immune response to HIV.
Perreau M, Levy Y, Pantaleo G. Perreau M, et al. Among authors: levy y. Curr Opin HIV AIDS. 2013 Jul;8(4):333-40. doi: 10.1097/COH.0b013e328361faf4. Curr Opin HIV AIDS. 2013. PMID: 23743723 Review.
Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants.
Frey SE, Peiperl L, McElrath MJ, Kalams S, Goepfert PA, Keefer MC, Baden LR, Lally MA, Mayer K, Blattner WA, Harro CD, Hammer SM, Gorse GJ, Hural J, Tomaras GD, Levy Y, Gilbert P, deCamp A, Russell ND, Elizaga M, Allen M, Corey L. Frey SE, et al. Among authors: levy y. Clin Vaccine Immunol. 2014 Nov;21(11):1589-99. doi: 10.1128/CVI.00450-14. Epub 2014 Sep 24. Clin Vaccine Immunol. 2014. PMID: 25253665 Free PMC article. Clinical Trial.
REACTing: the French response to infectious disease crises.
Delfraissy JF, Yazdanpanah Y, Levy Y. Delfraissy JF, et al. Among authors: levy y. Lancet. 2016 May 28;387(10034):2183-5. doi: 10.1016/S0140-6736(16)30059-9. Epub 2016 May 1. Lancet. 2016. PMID: 27145708 Free PMC article. No abstract available.
Prevention of Ebola virus disease through vaccination: where we are in 2018.
Lévy Y, Lane C, Piot P, Beavogui AH, Kieh M, Leigh B, Doumbia S, D'Ortenzio E, Lévy-Marchal C, Pierson J, Watson-Jones D, Nguyen VK, Larson H, Lysander J, Lacabaratz C, Thiebaut R, Augier A, Ishola D, Kennedy S, Chêne G, Greenwood B, Neaton J, Yazdanpanah Y. Lévy Y, et al. Among authors: levy marchal c. Lancet. 2018 Sep 1;392(10149):787-790. doi: 10.1016/S0140-6736(18)31710-0. Epub 2018 Aug 10. Lancet. 2018. PMID: 30104048 Free PMC article. No abstract available.
1,338 results